Sphingosine kinase 1 (SPHK1) mRNA (SPHK1 mRNA)

SPHK1 mRNA is the messenger RNA transcript that encodes the enzyme Sphingosine kinase 1 [NCBI Gene, 2024]. This enzyme plays a critical role in the "sphingolipid rheostat" by phosphorylating sphingosine to form sphingosine-1-phosphate (S1P) [UniProt, 2024]. S1P is a bioactive lipid that acts as a signaling molecule to promote cell proliferation, survival, and migration through G protein-coupled receptors [Pyne et al., 2010]. Overexpression of SPHK1 mRNA is frequently observed in various malignancies, including breast, lung, and colon cancers, where it contributes to tumor growth and resistance to chemotherapy [Taha et al., 2004]. Beyond oncology, SPHK1 mRNA is implicated in inflammatory conditions and fibrotic diseases due to its role in cytokine production and tissue remodeling [Milstien & Spiegel, 2006]. Therapeutic strategies targeting SPHK1 mRNA include antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) designed to degrade the transcript and prevent protein synthesis [Xia et al., 2002]. These RNA-targeted approaches aim to provide higher specificity than traditional small molecule inhibitors, which often struggle to differentiate between SPHK1 and its isoform SPHK2 [Pitman et al., 2016]. Current research focuses on optimizing delivery systems to ensure these RNA-based drugs reach target tissues effectively while minimizing off-target effects [Wang et al., 2019].

Other names

Sphingosine kinase 1 messenger RNASPHK1 transcriptSPK1 mRNA

RNA interference (siRNA) or antisense-mediated degradation (ASO) of the SPHK1 transcript, leading to reduced translation and knockdown of the Sphingosine kinase 1 protein.